Morgan Stanley Bio Rad Laboratories, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Morgan Stanley holds 196,624 shares of BIO stock, worth $51.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

196,624

Previous 248,286 20.81%

Holding current value

$51.9 Million

Previous $81.6 Million 41.29%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$243.0 - $367.0 $12.6 Million - $19 Million	-51,662 Reduced 20.81%	196,624 $47.9 Million
Q4 2024 Feb 14, 2025	BUY	$313.15 - $374.28 $19.2 Million - $23 Million	61,334 Added 32.81%	248,286 $81.6 Million
Q3 2024 May 14, 2025	SELL	$263.97 - $344.64 $7.94 Million - $10.4 Million	-30,064 Reduced 13.85%	186,952 $62.6 Million
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $7.94 Million - $10.4 Million	-30,064 Reduced 13.85%	186,952 $62.6 Million
Q2 2024 May 14, 2025	SELL	$268.26 - $339.48 $8.39 Million - $10.6 Million	-31,270 Reduced 12.59%	217,016 $59.3 Million
Q2 2024 Oct 17, 2024	SELL	$268.26 - $339.48 $9.48 Million - $12 Million	-35,324 Reduced 14.0%	217,016 $59.3 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $9.48 Million - $12 Million	-35,324 Reduced 14.0%	217,016 $59.3 Million
Q1 2024 Oct 17, 2024	BUY	$304.11 - $351.99 $10.7 Million - $12.4 Million	35,324 Added 16.28%	252,340 $87.3 Million
Q1 2024 Aug 16, 2024	BUY	$304.11 - $351.99 $690,025 - $798,665	2,269 Added 0.91%	252,340 $87.3 Million
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $690,025 - $798,665	2,269 Added 0.91%	252,340 $87.3 Million
Q4 2023 Aug 16, 2024	BUY	$269.37 - $365.04 $8.9 Million - $12.1 Million	33,055 Added 15.23%	250,071 $80.7 Million
Q4 2023 Feb 13, 2024	BUY	$269.37 - $365.04 $9.75 Million - $13.2 Million	36,183 Added 16.92%	250,071 $80.7 Million
Q3 2023 Nov 15, 2023	BUY	$350.25 - $422.63 $5.05 Million - $6.09 Million	14,408 Added 7.22%	213,888 $76.7 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $1.89 Million - $2.56 Million	5,263 Added 2.71%	199,480 $75.6 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $1.3 Million - $1.56 Million	3,096 Added 1.62%	194,217 $93 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $18.8 Million - $24.4 Million	53,491 Added 38.87%	191,121 $80.4 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $2.22 Million - $3.03 Million	-5,379 Reduced 3.76%	137,630 $57.4 Million
Q2 2022 Oct 27, 2022	BUY	$463.67 - $597.16 $35.6 Million - $45.9 Million	76,782 Added 115.94%	143,009 $70.8 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $35.6 Million - $45.9 Million	76,782 Added 115.94%	143,009 $70.8 Million
Q1 2022 Oct 27, 2022	SELL	$524.57 - $735.42 $40.3 Million - $56.5 Million	-76,782 Reduced 53.69%	66,227 $37.3 Million
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $25.6 Million - $36 Million	-48,897 Reduced 42.47%	66,227 $37.3 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $31.3 Million - $35.1 Million	44,201 Added 62.32%	115,124 $87 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $46.6 Million - $58.6 Million	70,923 New	70,923 $52.9 Million

Others Institutions Holding BIO

# of Institutions

452

Shares Held

18.7M

Call Options Held

12.7K

Put Options Held

14.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.51B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account